Community-acquired paediatric pneumonia (CAPP). Is antibiotic treatment universally required?

S. Quintas, A. Boto, L. Pereira, C. Barreto, L. Lito, T. Bandeira (Lisboa, Portugal)

Source: Annual Congress 2001 - New insights in viral and bacterial lung infection in children
Session: New insights in viral and bacterial lung infection in children
Session type: Poster Discussion
Number: 1142
Disease area: Paediatric lung diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Quintas, A. Boto, L. Pereira, C. Barreto, L. Lito, T. Bandeira (Lisboa, Portugal). Community-acquired paediatric pneumonia (CAPP). Is antibiotic treatment universally required?. Eur Respir J 2001; 16: Suppl. 31, 1142

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Relevance of correct antibiotic choice in community-acquired pneumonia (CAP)
Source: Annual Congress 2005 - Community-acquired pneumonia: clinical approaches
Year: 2005


Antibacterial class is not obviously important in outpatient pneumonia: a meta-analysis
Source: Eur Respir J 2008; 31: 1068-1076
Year: 2008



Cost-effective antibiotic management of community acquired pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=198
Year: 2004

PATS and ERS paediatric webinar: reducing the burden of CAP
Source: ERS webinar 2021: PATS and ERS paediatric webinar: reducing the burden of CAP
Year: 2021

Antibiotic usage analysis for community-acquired pneumonia (CAP) treatment
Source: Annual Congress 2009 - Pulmonary infections
Year: 2009


Community-acquired pneumonia: severity and antibiotic treatments
Source: ERS Course 2018 - Respiratory Infections
Year: 2018

Adherence to guidelines' empirical antibiotic recommendations and community-acquired pneumonia outcome
Source: Eur Respir J 2008; 32: 892-901
Year: 2008



Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia
Source: Eur Respir J 2011; 37: 1332-1339
Year: 2011



Timing of antibiotic administration and outcomes for patients with community-acquired pneumonia (CAP). NAC-CV Study
Source: Eur Respir J 2006; 28: Suppl. 50, 349s
Year: 2006

Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia
Source: Eur Respir J 2010; 36: 128-134
Year: 2010



Emergency treatment of communityacquired pneumonia
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=183
Year: 2006

Community-acquired pneumonia trough enterobacteriaceae and p. aeruginosa: diagnosis, incidence, and predictors. The German CAPNETZ
Source: Annual Congress 2009 - Respiratory infection caused by Pseudomonas aeruginosa
Year: 2009

Clinical stability and switch therapy in hospitalised patients with community-acquired pneumonia: are we there yet?
Source: Eur Respir J 2013; 41: 5-6
Year: 2013


Are corticosteroids useful in community-acquired pneumonia?
Source: Annual Congress 2006 - Evaluation of risk factors in community-acquired pneumonia
Year: 2006


Community-acquired pneumonia guidelines: much guidance, but not much evidence
Source: Eur Respir J 2002; 20: 1-3
Year: 2002


Antibiotic treatment for nosocomial pneumonia
Source: ISSN=1025-448x, ISBN=1-904097-32-4, page=211
Year: 2004

Community-acquired pneumonia in outpatients: aetiology and outcomes},
Source: Eur Respir J 2012; 40: 931-938
Year: 2012



Community-acquired pneumonia
Source: Respipedia Article
Year: 2017

Treatment failure in pneumonia: impact of antibiotic treatment and cost analysis
Source: Eur Respir J 2012; 39: 611-618
Year: 2012